Document Type
Journal Article
Publication Title
International Journal of Molecular Sciences
ISSN
16616596
Volume
21
Issue
21
First Page
1
Last Page
20
Publisher
MDPI
School
School of Medical and Health Sciences
RAS ID
35333
Funders
Torrens University Australia Curtin University
Abstract
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Type 2 diabetes (T2D) and Alzheimer’s disease (AD) are growing in prevalence worldwide. The development of T2D increases the risk of AD disease, while AD patients can show glucose imbalance due to an increased insulin resistance. T2D and AD share similar pathological features and underlying mechanisms, including the deposition of amyloidogenic peptides in pancreatic islets (i.e., islet amyloid polypeptide; IAPP) and brain (β-Amyloid; Aβ). Both IAPP and Aβ can undergo misfolding and aggregation and accumulate in the extracellular space of their respective tissues of origin. As a main response to protein misfolding, there is evidence of the role of heat shock proteins (HSPs) in moderating T2D and AD. HSPs play a pivotal role in cell homeostasis by providing cytoprotection during acute and chronic metabolic stresses. In T2D and AD, intracellular HSP (iHSP) levels are reduced, potentially due to the ability of the cell to export HSPs to the extracellular space (eHSP). The increase in eHSPs can contribute to oxidative damage and is associated with various pro-inflammatory pathways in T2D and AD. Here, we review the role of HSP in moderating T2D and AD, as well as propose that these chaperone proteins are an important link in the relationship between T2D and AD.
DOI
10.3390/ijms21218204
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Rowles, J. E., Keane, K. N., Gomes Heck, T., Cruzat, V., Verdile, G., & Newsholme, P. (2020). Are heat shock proteins an important link between type 2 diabetes and Alzheimer disease?. International Journal of Molecular Sciences, 21(21), article 8204. https://doi.org/10.3390/ijms21218204